Analyst Ratings for Summit Therapeutics plc (SMMT)
SMMT Rating Summary
SMMT Price Target Summary
- Highest: $43.00 (Citi)
- Lowest: $11.90 (Bernstein SocGen Group)
- Average: $29.45
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.45 (+101.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$29.45 (+101.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Jefferies » Updated 9/29/2026 |
Faisal Khurshid | Upgrade | Buy (Hold) |
30.00 (25.00) |
17.28 (14.63) |
-15.34% | Details |
| 8/25/2026 | Bernstein SocGen Group » Updated 10/5/2026 |
Jeffrey Walch | Upgrade | Market Perform (Underperform) |
11.90 (N/A) |
13.16 (14.63) |
11.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
